Drug intelligence / Profile preview

phytosterol esters of omega-3

Development stage
Unknown
Lead developer
Daewon Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Phytosterol esters of omega-3 is a **combination product consisting of omega-3 fatty acids (primarily eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) esterified with plant-derived phytosterols**[2][7][5][8]. This dual-action supplement is designed to modulate lipid metabolism with two synergistic mechanisms: - Omega-3 fatty acids reduce hepatic triglyceride synthesis and increase fatty acid oxidation, thereby lowering triglyceride concentrations. - Phytosterol esters impair absorption of dietary cholesterol in the intestine by competing with cholesterol for incorporation into mixed micelles, reducing serum LDL cholesterol. Clinical trial evidence suggests that n-3-PSE can reduce **triglycerides (by ~19%)** without an associated increase in LDL cholesterol (which is commonly seen with omega-3 monotherapy), and may also lower blood pressure and inflammation markers such as hsCRP[2][7][8]. Studies indicate additional potential benefit in improving hepatic steatosis in non-alcoholic fatty liver disease (NAFLD)[7][9].

Brand names
Vayarol
Other names
n-3-PSEn3-PSEn 3-PSEomega-3 plant sterol estersomega3 plant sterol estersomega 3 plant sterol estersomega-3–phytosterol esterphytosterol omega-3 ester
02

Targets

DGAT1 (Diacylglycerol O-acyltransferase 1)LPL (Lipoprotein lipase)NPC1L1 (Niemann-pick C1-Like 1 transporter)

Beyond the preview

Go deeper on phytosterol esters of omega-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phytosterol esters of omega-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call